Rohini Sigireddi, M.D.
NPI 1457811440 · Cornea and External Diseases Specialist Physician · Houston, TX
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Rohini Sigireddi, M.D. is a Cornea and External Diseases Specialist Physician provider in Houston, TX (NPI 1457811440).
Provider details
- NPI number
- 1457811440
- Entity type
- Individual
- Primary specialty
- Cornea and External Diseases Specialist PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- Yes
- License
- W0298 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
7 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 4 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Prednisolone Acetate | 33 | 29 |
| Acetazolamidebrand: Acetazolamide Er | 16 | — |
| Ofloxacin | 13 | 11 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 12 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$188 across 4 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2019-03-25
- Last updated
- 2025-09-01
- Certified
- 2025-09-01
Frequently asked questions
- What is Rohini Sigireddi's NPI number?
- Rohini Sigireddi's National Provider Identifier (NPI) is 1457811440, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Rohini Sigireddi's specialty?
- Rohini Sigireddi is listed in the NPPES registry with a primary specialty of Cornea and External Diseases Specialist Physician (Allopathic & Osteopathic Physicians).
- Where is Rohini Sigireddi located?
- Rohini Sigireddi's practice location on file with NPPES is 6400 Fannin St Ste 1800, Houston, TX 77030-1526.
- What is Rohini Sigireddi's phone number?
- The practice phone number listed in the NPPES registry for Rohini Sigireddi is (713) 486-9400.
- Does Rohini Sigireddi accept Medicare?
- Rohini Sigireddi is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Rohini Sigireddi's NPI active?
- Yes — Rohini Sigireddi's NPI (1457811440) is active in the NPPES registry as of the last update on 2025-09-01.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.